In light of the multi-stakeholder hearings on TB, PPR, and UHC that took place between the 8-9th of May and the release of the zero drafts for the HLM on TB and on UHC, STOPAIDS and partners have released a series of briefings for advocates participating in the upcoming negotiations for the political declarations and … Continued
This report, part of the Access Denied series, explores the role that UK public entities have played in supporting the development of COVID-19 tools such as diagnostics, vaccines and treatments. It highlights how the lack of equitable access safeguards across the research and development (R&D) continuum results in the perpetuation of an extractive global health … Continued
Three years on, the COVID-19 pandemic has officially caused the deaths of over 7 million people, disrupting livelihoods globally and continuing to have a devastating impact on communities that don’t have widespread access to health technologies. The world’s response to the pandemic has demonstrated the flaws in the existing global system for the research, development … Continued
STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes. The series is structured into two reports. The first set the scene through speaking to key actors and stakeholders who were involved in or following the contract negotiations. In … Continued
The 24th International AIDS Conference convened by the International AIDS Society took place in Montréal, Canada. This was a key moment for HIV activists, policy makers and the public health community to come together and STOPAIDS was delighted to participate both in person and virtually. To revisit the timetable of STOPAIDS and member events: … Continued
Quality of life (QoL) is an essential issue for all people, regardless of whether they are living with HIV or not. This factsheet is intended to be used as a good practice guide for STOPAIDS members and the wider international development sector. The paper takes a whole-life-course approach and highlights best-practice case studies from across … Continued
https://stopaids.org.uk/wp-content/uploads/2020/04/Equitable-access-to-COVID-19-diagnostics-vaccines-and-treatments-1-1.pdf
The Factsheet explores how STOPAIDS members, allies and partners are leading by example in their efforts to couple the advancement of the HIV response with the achievement of UHC. It identifies six key thematic building blocks of the HIV response which we believe will also underpin UHC. Within these we analyse the lessons from the … Continued
Since we first started in 1986, STOPAIDS has advocated for a human rights-based approach to ending AIDS. We have particularly focused on promoting the human rights of key population groups who are disproportionately impacted by HIV – including sex workers, men who have sex with men, transgender people and people who use drugs. In this … Continued
Girls and young women aged 15-24 years in sub-Saharan Africa are up to eight times more likely to be HIV positive compared to boys and men of the same age. This age group is expected to double in sub-Saharan Africa in the next decade and therefore urgent action is needed to end the epidemic and prevent a resurgence of HIV. In stepping up its work against gender-based health inequalities, the Global Fund has more than quadrupled investments to reduce new HIV infections for adolescent girls and young women in sub-Saharan Africa with strong community-based prevention programmes. The Global Fund has also recently set a bold target to reduce the number of new HIV infections among adolescent girls and young women by 58% in 13 African countries over the next five years as part of their HER: HIV Epidemic Response campaign.